Arformoterol Tartrate
Product Images NDC 0093-5955

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Arformoterol Tartrate (NDC 0093-5955). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Chemical structure diagram showing the molecular structure of Arformoterol tartrate, including its key functional groups and stereochemistry as part of the combined molecule.*

FDA Label Image

1 (Image 10)

Packaging label for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL by Teva Pharmaceuticals USA, Inc. The label indicates the product contains 60 sterile unit-dose ampules, each 2 mL. It instructs to keep refrigerated or store at room temperature for up to 6 weeks and indicates the solution is for oral inhalation only.*

FDA Label Image

1 (Image 11)

Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL sterile unit-dose ampules. The label indicates potency expressed as arformoterol for oral inhalation use only. The package contains 60 x 2 mL ampules (12 trays of 5 unit-dose ampules each) and is labeled for storage refrigerated or at room temperature up to 6 weeks. Manufactured for Teva Pharmaceuticals USA, Inc., the label includes storage, usage instructions, and a barcode.*

FDA Label Image

1 (Image 2)

A line graph showing mean change from baseline FEV1 (liters) over 12 hours postdose comparing placebo and 15 mcg Arformoterol Tartrate BID. The x-axis represents hours postdose, and the y-axis shows mean change from baseline FEV1. The graph shows greater improvement with Arformoterol Tartrate compared to placebo.*

FDA Label Image

1 (Image 3)

A line graph showing mean change from baseline FEV1 (L) over 12 hours postdose for placebo and 15 mcg Arformoterol Tartrate BID groups. The graph compares lung function change, with Arformoterol Tartrate group showing higher improvement than placebo across the time points.*

FDA Label Image

1 (Image 4)

An instructional line drawing labeled Figure 1 shows a hand holding a vial with its cap being twisted or removed, indicated by an arrow demonstrating the direction of rotation. This illustration likely demonstrates proper vial cap removal technique.*

FDA Label Image

1 (Image 5)

An instructional illustration showing a hand holding and using a dropper or vial to place liquid into a labeled reservoir component, identified as Figure 2. The drawing is simple and focuses on demonstrating the method of filling the reservoir.*

FDA Label Image

1 (Image 6)

Illustration showing a medical device mouthpiece attachment. The diagram indicates the location of the mouthpiece on the device, likely related to Arformoterol tartrate inhalation delivery.*

FDA Label Image

1 (Image 7)

An instructional illustration labeled Figure 4 showing proper use of a face mask attached to a medical device or inhaler. The diagram highlights placement of the face mask over the mouth and nose for device administration.*

FDA Label Image

1 (Image 8)

An instructional illustration labeled 'Figure 5' showing a close-up view of a compressor unit with a port labeled 'TUBING' where a tube is connected. The image highlights the part of the medical device relevant to the assembly or use of the compressor tubing.*

FDA Label Image

1 (Image 9)

An instructional line drawing showing a person holding an inhaler device near their mouth, preparing to inhale the medication. The person's profile is visible, and the inhaler is depicted with a mouthpiece and a round canister.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.